日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Artibeus fraterculus Cytochrome b (MT-CYB), partial CSB-YP836064AIAM
CSB-EP836064AIAM
CSB-BP836064AIAM
CSB-MP836064AIAM
CSB-EP836064AIAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Artibeus inopinatus Cytochrome b (MT-CYB), partial CSB-YP836065AIAN
CSB-EP836065AIAN
CSB-BP836065AIAN
CSB-MP836065AIAN
CSB-EP836065AIAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana NADH dehydrogenase [ubiquinone] iron-sulfur protein 3 (NAD9) CSB-YP836066DOA
CSB-EP836066DOA
CSB-BP836066DOA
CSB-MP836066DOA
CSB-EP836066DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Myotis macrotarsus Cytochrome b (MT-CYB), partial CSB-YP836067MIAP
CSB-EP836067MIAP
CSB-BP836067MIAP
CSB-MP836067MIAP
CSB-EP836067MIAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Myotis capaccinii Cytochrome b (MT-CYB), partial CSB-YP836068MIAQ
CSB-EP836068MIAQ
CSB-BP836068MIAQ
CSB-MP836068MIAQ
CSB-EP836068MIAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eptesicus fuscus Cytochrome b (MT-CYB), partial CSB-YP836069ECAY
CSB-EP836069ECAY
CSB-BP836069ECAY
CSB-MP836069ECAY
CSB-EP836069ECAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Peromyscus maniculatus NADH-ubiquinone oxidoreductase chain 3 (MT-ND3), partial CSB-YP836070PGG1
CSB-EP836070PGG1
CSB-BP836070PGG1
CSB-MP836070PGG1
CSB-EP836070PGG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polypterus ornatipinnis NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP836071PKAP1
CSB-EP836071PKAP1
CSB-BP836071PKAP1
CSB-MP836071PKAP1
CSB-EP836071PKAP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Whiteheadia bifolia ATP synthase subunit beta, chloroplastic (atpB) CSB-YP836072WAAJ
CSB-EP836072WAAJ
CSB-BP836072WAAJ
CSB-MP836072WAAJ
CSB-EP836072WAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cannabis sativa Maturase K (matK), partial CSB-YP836073CWH
CSB-EP836073CWH
CSB-BP836073CWH
CSB-MP836073CWH
CSB-EP836073CWH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nicotiana rustica Maturase K (matK), partial CSB-YP836074NDM
CSB-EP836074NDM
CSB-BP836074NDM
CSB-MP836074NDM
CSB-EP836074NDM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opuntia quimilo Maturase K (matK), partial CSB-YP836075OBAV
CSB-EP836075OBAV
CSB-BP836075OBAV
CSB-MP836075OBAV
CSB-EP836075OBAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gaultheria procumbens Maturase K (matK), partial CSB-YP836076GDAK
CSB-EP836076GDAK
CSB-BP836076GDAK
CSB-MP836076GDAK
CSB-EP836076GDAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cercidiphyllum japonicum Translation initiation factor IF-1, chloroplastic (infA) CSB-YP836077CGQ
CSB-EP836077CGQ
CSB-BP836077CGQ
CSB-MP836077CGQ
CSB-EP836077CGQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Triticum aestivum NAD (P)H-quinone oxidoreductase subunit H, chloroplastic (ndhH) CSB-YP836078TQN
CSB-EP836078TQN
CSB-BP836078TQN
CSB-MP836078TQN
CSB-EP836078TQN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Triticum aestivum 50S ribosomal protein L14, chloroplastic (rpl14) CSB-YP836079TQN
CSB-EP836079TQN
CSB-BP836079TQN
CSB-MP836079TQN
CSB-EP836079TQN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Triticum aestivum NAD (P)H-quinone oxidoreductase subunit J, chloroplastic (ndhJ) CSB-YP836080TQN
CSB-EP836080TQN
CSB-BP836080TQN
CSB-MP836080TQN
CSB-EP836080TQN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorocebus aethiops Beta-defensin 1 (DEFB1) CSB-YP836081DSU
CSB-EP836081DSU
CSB-BP836081DSU
CSB-MP836081DSU
CSB-EP836081DSU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Monodelphis domestica Lutropin subunit beta (LHB) CSB-YP836082MUE
CSB-EP836082MUE
CSB-BP836082MUE
CSB-MP836082MUE
CSB-EP836082MUE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Liver-expressed antimicrobial peptide 2 (LEAP2) CSB-YP836083BO
CSB-EP836083BO
CSB-BP836083BO
CSB-MP836083BO
CSB-EP836083BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×